Melco Resorts & Entertainment Limited

TORONTO--(BUSINESS WIRE)--The More Life Company Corp. (the “Company” or “MLCO”), (CSE: MLCO) (OTC: TMLCF), is pleased to announce results from an exploratory eight-participant human pharmacokinetic study conducted with third-party medical personnel to evaluate United States Pharmacopeia (“USP”) grade testosterone formulated using the Company's patented Quicksome™ sublingual delivery technology. The study showed rapid systemic appearance of USP testosterone following Quicksome administration, wi.

TORONTO--(BUSINESS WIRE)--The More Life Company Corp. (the “Company” or “TMLC”) (CSE: MLCO) (OTCID: TMLCF) is pleased to report positive results from an independently conducted field trial evaluating the Company's licensed Agrarius™ agricultural plant signaling technology in potato crops in Brazil.The leading Agrarius application programs recorded numerical yield increases of up to 32.5% in special-grade potatoes and up to 27.6% in total potato yield compared with the control.The study was indep.

Melco Resorts & Entertainment NASDAQ: MLCO reported group-wide adjusted property EBITDA of approximately $304 million for the second quarter of 2026, as lower-than-expected visitation and an unfavorable VIP win rate weighed on margins in Macau.

The headline numbers for Melco (MLCO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.